Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
6.04
+0.04 (0.67%)
Apr 2, 2025, 11:41 AM CET

Hyloris Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
169183357311447245
Upgrade
Market Cap Growth
-48.71%-48.71%14.84%-30.44%82.10%-
Upgrade
Enterprise Value
146157319260402187
Upgrade
Last Close Price
6.026.5412.7511.6017.309.50
Upgrade
PS Ratio
18.2418.2484.72130.24144.351402.34
Upgrade
PB Ratio
5.705.709.145.779.304.16
Upgrade
P/TBV Ratio
6.476.479.575.979.674.26
Upgrade
EV/Sales Ratio
14.5615.6475.71108.83129.771068.71
Upgrade
Debt / Equity Ratio
0.060.060.050.020.180.14
Upgrade
Asset Turnover
0.230.230.080.040.050.01
Upgrade
Quick Ratio
4.124.125.148.323.5330.33
Upgrade
Current Ratio
4.154.155.228.633.6031.24
Upgrade
Return on Equity (ROE)
-17.81%-17.81%-33.08%-23.35%-21.62%-29.24%
Upgrade
Return on Assets (ROA)
-8.53%-8.53%-18.27%-11.58%-9.73%-8.44%
Upgrade
Return on Capital (ROIC)
-10.16%-10.16%-20.72%-12.88%-10.38%-9.00%
Upgrade
Earnings Yield
-3.76%-3.46%-4.31%-3.83%-2.59%-2.91%
Upgrade
FCF Yield
-3.99%-3.68%-3.67%-4.22%-2.54%-1.86%
Upgrade
Buyback Yield / Dilution
--2.95%-5.29%-18.40%-51.63%
Upgrade
Updated Oct 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.